Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -39.33% is 33% above its 5-year average of -58.52%, near the high end of its 5-year range (-99.03%–-38.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.41% above its 12-month average of -51.35%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -39.33%.
RETURN ON EQUITY (ROE)
-39.33%
RETURN ON EQUITY (ROE) AVG TTM
-51.35%
RETURN ON EQUITY (ROE) AVG 3Y
-57.46%
RETURN ON EQUITY (ROE) AVG 5Y
-58.52%
RETURN ON EQUITY (ROE) AVG 10Y
-52.02%
RETURN ON EQUITY (ROE) AVG 15Y
-48.27%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.41%
CURRENT VS 3Y AVG
+31.55%
CURRENT VS 5Y AVG
+32.78%
CURRENT VS 10Y AVG
+24.38%
CURRENT VS 15Y AVG
+18.50%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+6.37%
vs the sector median at left
Iovance Biotherapeutics, Inc.
Market Cap
$5.85B
Return on Equity (ROE)
-39.33%
TTM Avg
-51.35%
3Y Avg
-57.46%
5Y Avg
-58.52%
Market Cap
$5.86B
Return on Equity (ROE)
-15.40%
TTM Avg
-48.41%
3Y Avg
-63.30%
5Y Avg
-53.67%
Market Cap
$5.84B
Return on Equity (ROE)
-396.09%
TTM Avg
-131.69%
3Y Avg
-109.48%
5Y Avg
-82.27%
Market Cap
$5.88B
Return on Equity (ROE)
12.33%
TTM Avg
0.28%
3Y Avg
12.51%
5Y Avg
-14.51%
Market Cap
$5.93B
Return on Equity (ROE)
20.38%
TTM Avg
5.87%
3Y Avg
3.40%
5Y Avg
3.36%
Market Cap
$5.61B
Return on Equity (ROE)
-21.80%
TTM Avg
-16.70%
3Y Avg
-22.00%
5Y Avg
-23.98%
Market Cap
$5.52B
Return on Equity (ROE)
-1.93%
TTM Avg
-0.70%
3Y Avg
0.57%
5Y Avg
0.69%
Market Cap
$6.21B
Return on Equity (ROE)
-94.50%
TTM Avg
-115.58%
3Y Avg
-102.12%
5Y Avg
-85.25%
Market Cap
$5.50B
Return on Equity (ROE)
-9.09%
TTM Avg
-8.34%
3Y Avg
-4.98%
5Y Avg
-4.98%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Iovance Biotherapeutics, Inc. (IOVA) | $5.85B | -39.33% | -51.35% | -57.46% | -58.52% |
| GRAIL Inc. (GRAL)vs › | $5.86B | -15.40% | -48.41% | -63.30% | -53.67% |
| Kodiak Sciences Inc. (KOD)vs › | $5.84B | -396.09% | -131.69% | -109.48% | -82.27% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.88B | 12.33% | 0.28% | 12.51% | -14.51% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.93B | 20.38% | 5.87% | 3.40% | 3.36% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -21.80% | -16.70% | -22.00% | -23.98% |
| RadNet, Inc. (RDNT)vs › | $5.52B | -1.93% | -0.70% | 0.57% | 0.69% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.21B | -94.50% | -115.58% | -102.12% | -85.25% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.50B | -9.09% | -8.34% | -4.98% | -4.98% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.30B | N/A | -149.71% | -15.45% | -6097.55% |
ROE
-39.3%
ROA
-31.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -39.33% |
| 2026-03-31 | -49.03% |
| 2025-12-31 | -55.97% |
| 2025-09-30 | -56.62% |
| 2025-06-30 | -55.82% |
| 2025-03-31 | -48.88% |
| 2024-12-31 | -52.39% |
| 2024-09-30 | -53.01% |
| 2024-06-30 | -57.28% |
| 2024-03-31 | -66.12% |
| 2023-12-31 | -75.95% |
| 2023-09-30 | -64.24% |
| 2023-06-30 | -72.39% |
| 2023-03-31 | -61.73% |
| 2022-12-31 | -79.24% |
| 2022-09-30 | -99.03% |
| 2022-06-30 | -79.63% |
| 2022-03-31 | -64.93% |
| 2021-12-31 | -55.05% |
| 2021-09-30 | -44.58% |
| 2021-06-30 | -38.12% |
| 2021-03-31 | -41.00% |
| 2020-12-31 | -39.54% |
| 2020-09-30 | -35.79% |
| 2020-06-30 | -32.40% |
| 2020-03-31 | -94.61% |
| 2019-12-31 | -66.08% |
| 2019-09-30 | -46.91% |
| 2019-06-30 | -37.97% |
| 2019-03-31 | -30.81% |
| 2018-12-31 | -26.51% |
| 2018-09-30 | -45.98% |
| 2018-06-30 | -38.87% |
| 2018-03-31 | -33.46% |
| 2017-12-31 | -63.28% |
| 2017-09-30 | -49.50% |
| 2017-06-30 | -60.79% |
| 2017-03-31 | -44.50% |
| 2016-12-31 | -31.69% |
| 2016-09-30 | -25.45% |
| 2016-06-30 | -18.24% |
| 2016-03-31 | -29.58% |
| 2015-12-31 | -26.61% |
| 2015-09-30 | -22.10% |
| 2015-06-30 | -17.13% |
| 2015-03-31 | -13.50% |
| 2014-12-31 | -26.84% |
| 2014-09-30 | -115.51% |
| 2014-06-30 | -145.44% |
| 2014-03-31 | -158.25% |
| 2013-12-31 | -144.19% |
| 2010-12-31 | -252.05% |
| 2010-09-30 | -193.89% |
| 2010-06-30 | -37.83% |
| 2010-03-31 | -15.33% |
